Indoco Remedies Limited

General information

Indoco Remedies Ltd., headquartered in Mumbai, is a fully integrated, research-oriented Indian Pharma Company with presence in 55 countries. Indoco, a USD 165 million company, employs over 6000 people including over 300 skilled scientists.

The company has 9 manufacturing facilities, out of which 6 are for finished dosages and 3 for APIs and supported by a state-of-the-art R&D centre at Rabale, Navi Mumbai. The facilities have been approved by various regulatory authorities such as USFDA, UK-MHRA, SUKL-Czech Republic, Cofepris – Mexico, TGA-Australia, JAZMP- Slovenia, MCC-South Africa, NDA-Uganda, TFDA-Tanzania, SBD-Yemen, MOH-Ukraine, PPB-Kenya and FDB-Ghana.

Indoco develops, manufactures and distributes a wide range of pharmaceutical products for the Indian and international markets. It generates more than 70 million prescriptions annually from over 4,65,000 doctors in India. Indoco’s 9 domestic marketing divisions cater to different therapeutic segments including Respiratory, Anti-Infectives, Dental Care, Pain Management, Gastroenterology, Opthalmic, Cardiovascular, Anti-Diabetics, Anti-Obesity, etc. Top Indoco brands include Cyclopam, Febrex Plus, Sensodent-K, ATM, Oxipod, Cital, Sensoform, Cloben-G, Sensodent – KF, Karvol Plus, Glychek, Vepan, Tuspel Plus, Flamar, etc.

With one foot firmly entrenched in the fast growing Indian Pharma Market and the other in the vast International market, Indoco is beautifully poised to achieve greater heights.